We are live on ! Find out more
ACIU icon

AC Immune

19 hedge funds and large institutions have $113M invested in AC Immune in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

15.79% more ownership

Funds ownership: 0%15.79% (+16%)

17% less capital invested

Capital invested by funds: $136M → $113M (-$23.1M)

39% less funds holding

Funds holding: 3119 (-12)

69% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 16

Holders
19
Holders Change
-12
Holders Change %
-38.71%
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
7
Reduced
2
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$46.3M +$5.94M +428,815 +13%
DFO
2
Duquesne Family Office
New York
$20.5M +$1.09M +79,031 +5%
Temasek Holdings
3
Temasek Holdings
Singapore
$17.4M
PC
4
PointState Capital
New York
$10.1M +$4.84M +350,000 +82%
HIM
5
Hillhouse Investment Management
Cayman Islands
$7.14M
Citadel Advisors
6
Citadel Advisors
Florida
$4.85M +$4.13M +298,615 +399%
AG
7
Artal Group
Luxembourg
$3.25M +$1.38M +100,000 +67%
Millennium Management
8
Millennium Management
New York
$954K +$296K +21,409 +41%
AA
9
ALPS Advisors
Colorado
$691K +$737K +53,235 New
GCP
10
GSA Capital Partners
United Kingdom
$457K +$488K +35,233 New
Geode Capital Management
11
Geode Capital Management
Massachusetts
$329K +$56.7K +4,094 +19%
MIM
12
Monashee Investment Management
Massachusetts
$223K +$238K +17,168 New
Victory Capital Management
13
Victory Capital Management
Texas
$195K
Goldman Sachs
14
Goldman Sachs
New York
$136K -$258K -18,616 -64%
Morgan Stanley
15
Morgan Stanley
New York
$84K -$87.7K -6,336 -49%
AIM
16
Acrospire Investment Management
Illinois
$73K +$77.9K +5,626 New
CLOS
17
Compagnie Lombard Odier SCmA
Switzerland
$26K
CCA
18
Catalyst Capital Advisors
New York
$4K
Wells Fargo
19
Wells Fargo
California
$3K +$3.46K +250 New
Adage Capital Partners
20
Adage Capital Partners
Massachusetts
-$1.65M -100,000 Closed
HCMT
21
Highland Capital Management (Texas)
Texas
-$1.45M -87,900 Closed
Alyeska Investment Group
22
Alyeska Investment Group
Illinois
-$1.4M -85,000 Closed
SFM
23
Sphera Funds Management
Israel
-$1.31M -79,800 Closed
WAM
24
Wolverine Asset Management
Illinois
-$988K -60,000 Closed
American Century Companies
25
American Century Companies
Missouri
-$780K -47,348 Closed

ACIU Hedge Fund Activity: Q4 2016 in Review

19 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2016, worth a combined $113M — down 17% from $136M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ACIU and 5 opened new positions — a net loss of 11 holders — while 2 trimmed existing stakes and 7 added.

The largest buyer was Fidelity Investments, adding an estimated $5.94M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $1.65M sold.

  • 19 institutional investors held AC Immune (ACIU) as of Q4 2016, down from 31 in Q3 2016.
  • Funds reported $113M of AC Immune stock for Q4 2016, down 17% quarter-over-quarter.
  • 5 funds opened new AC Immune positions in Q4 2016 and 16 closed out, a net change of -11 holders.
  • The largest AC Immune buyer in Q4 2016 was Fidelity Investments, an estimated $5.94M added.
  • The largest AC Immune seller in Q4 2016 was Adage Capital Partners, an estimated $1.65M sold.

Based on aggregated 13F filings for Q4 2016.